TN2013000187A1 - Pharmaceutical composition, methods for treating and uses thereof - Google Patents

Pharmaceutical composition, methods for treating and uses thereof

Info

Publication number: TN2013000187A1
Authority: TN; Tunisia
Prior art keywords: treating; methods; pharmaceutical composition; type; diabetes mellitus
Prior art date: 2011-11-07

Application number

TNP2013000187A

Other languages

English (en)

Inventor

Rolf Grempler

Odd-Erik Johansen

Thomas Klein

Gerd Luippold

Michael Mark

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-11-07

Filing date

2013-04-29

Publication date

2014-11-10

2011-11-07 Priority claimed from PCT/EP2011/069532 external-priority patent/WO2012062698A1/fr

2013-04-29 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2014-11-10 Publication of TN2013000187A1 publication Critical patent/TN2013000187A1/fr

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
208000002705 Glucose Intolerance Diseases 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 abstract 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
201000001421 hyperglycemia Diseases 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
208000030159 metabolic disease Diseases 0.000 abstract 1
201000009104 prediabetes syndrome Diseases 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

TNP2013000187A 2011-11-07 2013-04-29 Pharmaceutical composition, methods for treating and uses thereof TN2013000187A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/EP2011/069532 WO2012062698A1 (fr)	2010-11-08	2011-11-07	Composition pharmaceutique, méthodes de traitement et leurs utilisations

Publications (1)

Publication Number	Publication Date
TN2013000187A1 true TN2013000187A1 (en)	2014-11-10

Family

ID=54360619

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2013000187A TN2013000187A1 (en)	2011-11-07	2013-04-29	Pharmaceutical composition, methods for treating and uses thereof

Country Status (1)

Country	Link
TN (1)	TN2013000187A1 (fr)

2013
- 2013-04-29 TN TNP2013000187A patent/TN2013000187A1/fr unknown

Similar Documents

Publication	Publication Date	Title
PH12018500767A1 (en)	2019-03-25	Pharmaceutical composition, methods for treating and uses thereof
PH12013500808A1 (en)	2015-10-07	Pharmaceutical combinations for the treatment of metabolic disorders
PH12016501607B1 (en)	2024-02-21	Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
TN2011000415A1 (en)	2013-03-27	Pharmaceutical composition comprising a sglt2 inhibitor a dpp-i v inhibitor and optionally a further antidiabetic agent and uses thereof
PH12020500352A1 (en)	2021-01-11	Therapeutic uses of empagliflozin
UA100384C2 (en)	2012-12-25	Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative
MX2010001560A (es)	2010-03-11	Composicion farmaceutica que comprende un inhibidor de sglt2 en combinacion con un inhibidor de dpp-iv.
EA201101187A1 (ru)	2012-10-30	Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
EP2217596B8 (fr)	2013-11-20	Dérivés hétérocycliques bicycliques et leur utilisation en tant que modulateurs de l'activite du gpr 119
MX378422B (es)	2025-03-10	Uso de empagliflozina para el tratamiento de trastornos metabòlicos, la prevenciòn, y para la reducciòn del riesgo de sufrir o para retrasar la ocurrencia de un episodio cardiovascular.
WO2010029089A3 (fr)	2010-05-06	Polythérapie pour le traitement du diabète et des états pathologiques apparentés
EP4327867A3 (fr)	2024-05-29	Composition pharmaceutique comprenant des dérivés de glucopyranosyldiphénylméthane, forme pharmaceutique correspondante, procédé pour leur préparation et utilisations
PH12014500075A1 (en)	2014-02-17	Pharmaceutical composition, methods for treating and uses thereof
PH12014502448A1 (en)	2015-01-12	Pharmaceutical combinations for the treatment of metabolic disorders
MX2012006734A (es)	2012-07-03	Tiazolidinadionas moderadoras de receptores activados por proliferador de peroxisoma (ppar) y combinaciones para el tratamiento de obesidad y otras enfermedades metabolicas.
TN2013000187A1 (en)	2014-11-10	Pharmaceutical composition, methods for treating and uses thereof
WO2014014816A3 (fr)	2014-05-08	Méthodes de traitement de troubles du métabolisme du glucose